Nocturia, also called nycturia (Greek νυκτουρία), is defined by the International Continence Society (ICS) as “the complaint that the individual has to wake at night one or more times for voiding (i.e. to urinate).” Its causes are varied and, in many patients, difficult to discern.
Antispasmodic Drug Type Segment to Exhibit a High Growth Rate During the Forecast Period.
Market Analysis and Insights: Global Nocturia Market
In 2019, the global Nocturia market size was US$ 2039.4 million and it is expected to reach US$ 3180.5 million by the end of 2026, with a CAGR of 6.5% during 2021-2026.
Global Nocturia Scope and Market Size
Nocturia market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nocturia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Nocturia market is segmented into Anticholinergic Drugs, Desmopressin, Antibiotics, Antispasmodic, Others, etc.
Segment by Application, the Nocturia market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, etc.
Regional and Country-level Analysis
The Nocturia market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nocturia market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Nocturia Market Share Analysis
Nocturia market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Nocturia business, the date to enter into the Nocturia market, Nocturia product introduction, recent developments, etc.
The major vendors include Allergan, Urigen Pharmaceuticals, Ferring Pharmaceuticals, Glenmark Pharmaceuticals, Teva Pharmaceutical Industries, AA Pharma, Avadel Pharmaceuticals, etc.

This report focuses on the global Nocturia status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nocturia development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Allergan
Urigen Pharmaceuticals
Ferring Pharmaceuticals
Glenmark Pharmaceuticals
Teva Pharmaceutical Industries
AA Pharma
Avadel Pharmaceuticals
...

Market segment by Type, the product can be split into

Anticholinergic Drugs
Desmopressin
Antibiotics
Antispasmodic
Others

Market segment by Application, split into

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Nocturia status, future forecast, growth opportunity, key market and key players.
To present the Nocturia development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Nocturia are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.